Mark Andrew Sherman sold $3.4M of DLB
EVP, Gen. Counsel & Secretary at Dolby Laboratories, Inc.. 40,000 shares at an average of $84.88, traded Jan 30, 2025, filed Feb 3, 2025.
Score components
- +15RoleOfficer
- +25Trade size$3.4M at market
- +10Share of holdings soldSold 39% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -1.9%, 3m -10.9%, 6m -13.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-012643, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 30, 2025 | MOption exercise Class A Common Stock10b5-1 | +40,000 | $62.32 | $2.5M | 102,397 | Feb 3, 2025 |
| Jan 30, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -15,000 | $83.00 | $1.2M | 87,397 | Feb 3, 2025 |
| Jan 30, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -25,000 | $86.00 | $2.2M | 62,397 | Feb 3, 2025 |
| Jan 30, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -40,000 | $0.00 | $0 | 16,000 | Feb 3, 2025 |
Related signals
Other insiders at Dolby Laboratories, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $451k 7,667 shares | -4% | |
| 5Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $468k 7,667 shares | -6% | |
| 38Weak | Dolby Laboratories, Inc. | Ryan Nicholson VP, CAO and Corp. Controller | $77k 1,183 shares | -3% | |
| 22Weak | Dolby Laboratories, Inc. | Shriram Revankar SVP, Advanced Technology Group | $188k 3,000 shares | -4% | |
| 39Weak | Dolby Laboratories, Inc. | Ryan Nicholson VP, CAO and Corp. Controller | $84k 1,348 shares | -4% | |
| 30Weak | Dolby Laboratories, Inc. | Ryan Nicholson VP, CAO and Corp. Controller | $22k 357 shares | -1% | |
| 12Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $460k 7,667 shares | -6% | |
| 0Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $408k 7,667 shares | -6% | |
| 5Weak | Dolby Laboratories, Inc. | John D Couling SVP, Entertainment | $426k 7,666 shares | -6% | |
| 55Moderate | Dolby Laboratories, Inc. | Todd Pendleton SVP, Chief Marketing Officer | $648k 11,876 shares | -22% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.